R. Krupa

发表

Targeted proteomics for metabolic pathway optimization: application to terpene production.

J. Keasling, P. Adams, C. Petzold, 2011, Metabolic engineering.

Title : Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer

David S. K. Lu, H. Vargas, H. Scher, 2017 .

Detection and Characterization of Circulating Tumour Cells from Frozen Peripheral Blood Mononuclear Cells

David S. K. Lu, J. Schlom, M. Landers, 2015, Journal of circulating biomarkers.

Androgen receptor expression on circulating tumor cells in metastatic breast cancer

Yipeng Wang, N. Ueno, J. Reuben, 2017, PloS one.

Circulating Tumor Cell Subtypes and T-cell Populations as Prognostic Biomarkers to Combination Immunotherapy in Patients with Metastatic Genitourinary Cancer A C

S. Steinberg, Yipeng Wang, J. Trepel, 2021 .

Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival

David S. K. Lu, S. Makani, D. Boffa, 2017, Cancer Epidemiology, Biomarkers & Prevention.

Identification of Human Embryonic Progenitor Cell Targeting Peptides Using Phage Display

E. Snyder, W. Funk, P. Bignone, 2013, PloS one.

Heterogeneity of prostate-specific membrane antigen (PSMA) expression in classic and apoptotic circulating tumor cells (CTC) in metastatic castration-resistant prostate cancer (mCRPC).

H. Scher, R. Krupa, J. Louw, 2014 .

Selection of Phage Display Peptides Targeting Human Pluripotent Stem Cell-Derived Progenitor Cell Lines.

P. Bignone, M. West, R. Krupa, 2016, Methods in molecular biology.

Development of an immunofluorescent AR-V7 circulating tumor cell assay – A blood-based test for men with metastatic prostate cancer

David S. K. Lu, H. Scher, R. Krupa, 2020, Journal of circulating biomarkers.

Circulating Tumor Cell Subtypes and T-cell Populations as Prognostic Biomarkers to Combination Immunotherapy in Patients with Metastatic Genitourinary Cancer

S. Steinberg, Yipeng Wang, J. Trepel, 2020, Clinical Cancer Research.

BglBrick vectors and datasheets: A synthetic biology platform for gene expression

Meghdad Hajimorad, Jay D Keasling, Fuzhong Zhang, 2011, Journal of biological engineering.

Molecular characterization of circulating tumor cells (CTC) and CTC subpopulations in baseline and progressive metastatic castration resistant prostate cancer (mCRPC).

H. Scher, D. Danila, R. Krupa, 2014 .

Abstract 1588: Single cell analysis of AR N terminal, AR C terminal and the ARv7 splice variant in the CTCs of metastatic castration resistant prostate cancer (mCRPC) patients

David S. K. Lu, H. Scher, D. Rathkopf, 2015 .

Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer.

David S. K. Lu, H. Vargas, H. Scher, 2017, Cancer research.

Phenotypic diversity of circulating tumour cells in patients with metastatic castration‐resistant prostate cancer

S. Tomlins, A. McDaniel, R. Ferraldeschi, 2017, BJU international.

The Initial Detection and Partial Characterization of Circulating Tumor Cells in Neuroendocrine Prostate Cancer

H. Beltran, J. Mosquera, H. Scher, 2015, Clinical Cancer Research.

Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients

David S. K. Lu, Yipeng Wang, T. Friedlander, 2016, BMC Cancer.

Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) and white blood cells (WBCs) in muscle invasive and metastatic bladder cancer patients.

David S. K. Lu, T. Friedlander, P. Paris, 2015 .

Phenotypic characterization of circulating tumor cells (CTCs) from neuroendocrine prostate cancer (NEPC) and metastatic castration-resistant prostate cancer (mCRPC) patients to identify a novel diagnostic algorithm for the presence of NEPC.

M. Rubin, H. Beltran, J. Mosquera, 2015 .